Live feed09:15:00·1dPRReleasevia QuantisnowCreative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back PainByQuantisnow·Wall Street's wire, on your screen.CELZ· Creative Medical Technology Holdings Inc.Finance
